BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Kudryavtseva A, Krasnov G. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World J Gastroenterol 2022; 28(10): 1067-1077 [PMID: 35431497 DOI: 10.3748/wjg.v28.i10.1067]
URL: https://www.wjgnet.com/1007-9327/full/v28/i10/1067.htm
Number Citing Articles
1
Irina Efremova, Roman Maslennikov, Elena Poluektova, Ekaterina Vasilieva, Yury Zharikov, Andrey Suslov, Yana Letyagina, Evgenii Kozlov, Anna Levshina, Vladimir Ivashkin. Epidemiology of small intestinal bacterial overgrowthWorld Journal of Gastroenterology 2023; 29(22): 3400-3421 doi: 10.3748/wjg.v29.i22.3400
2
Irina Efremova, Roman Maslennikov, Aliya Alieva, Elena Poluektova, Vladimir Ivashkin. Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in CirrhosisMicroorganisms 2023; 11(4): 1017 doi: 10.3390/microorganisms11041017
3
Paulina Roszkowska, Emilia Klimczak, Ewa Ostrycharz, Aleksandra Rączka, Iwona Wojciechowska-Koszko, Andrzej Dybus, Yeong-Hsiang Cheng, Yu-Hsiang Yu, Szymon Mazgaj, Beata Hukowska-Szematowicz. Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases—Current State of KnowledgeBiomedicines 2024; 12(5): 1030 doi: 10.3390/biomedicines12051030
4
Qi-Qi Xie, Jia-Feng Wang, Yang-Fen Zhang, Dong-Hui Xu, Bo Zhou, Ting-Hui Li, Zhi-Peng Li. Glucose substrate in the hydrogen breath test for gut microbiota determination: A recommended noninvasive testWorld Journal of Clinical Cases 2022; 10(26): 9536-9538 doi: 10.12998/wjcc.v10.i26.9536
5
André Pontes-Silva, André Luiz Lopes, Erika da Silva Maciel, Fernando Rodrigues Peixoto Quaresma, Almir Vieira Dibai-Filho. Human metabolism and body composition: prospects for novel studiesNutrition Reviews 2023; 82(1): 5 doi: 10.1093/nutrit/nuad040
6
Irina Efremova, Roman Maslennikov, Oleg Medvedev, Anna Kudryavtseva, Anastasia Avdeeva, George Krasnov, Filipp Romanikhin, Mikhail Diatroptov, Maria Fedorova, Elena Poluektova, Anna Levshina, Vladimir Ivashkin. Gut Microbiota and Biomarkers of Intestinal Barrier Damage in CirrhosisMicroorganisms 2024; 12(3): 463 doi: 10.3390/microorganisms12030463
7
Siyuan Sun, Guangheng Zhang, Shimeng Lv, Jinhui Sun. Potential mechanisms of traditional Chinese medicine in the treatment of liver cirrhosis: a focus on gut microbiotaFrontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1407991
8
Eden Sharabi, Ali Rezaie. Small Intestinal Bacterial OvergrowthCurrent Infectious Disease Reports 2024; 26(11): 227 doi: 10.1007/s11908-024-00847-7
9
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiotaWorld Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
10
Dmitry Victorovich Garbuzenko. Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosisWorld Journal of Hepatology 2023; 15(4): 525-537 doi: 10.4254/wjh.v15.i4.525
11
Ya-Nan Li, Na-Ling Kang, Jia-Ji Jiang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng, Fei Wang. Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changesWorld Journal of Gastroenterology 2022; 28(35): 5188-5202 doi: 10.3748/wjg.v28.i35.5188
12
Shiqi Zhang, Pinglan Li, Suwon Lee, Yu Wang, Chunming Tan, Nan Shang. Weizmannia coagulans: an Ideal Probiotic for Gut Health Food Science and Human Wellness 2023; : 1 doi: 10.26599/FSHW.2022.9250002
13
Irina Efremova, Roman Maslennikov, Maria Zharkova, Elena Poluektova, Nona Benuni, Aleksandr Kotusov, Tatyana Demina, Aleksandra Ivleva, Farida Adzhieva, Taisiya Krylova, Vladimir Ivashkin. Efficacy and Safety of a Probiotic Containing Saccharomyces boulardii CNCM I-745 in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis: Randomized, Placebo-Controlled StudyJournal of Clinical Medicine 2024; 13(3): 919 doi: 10.3390/jcm13030919
14
D.V. Garbuzenko. Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potentialDokazatel'naya gastroenterologiya 2022; 11(4): 65 doi: 10.17116/dokgastro20221104165
15
Aneta Kiecka, Marian Szczepanik. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probioticsPharmacological Reports 2023; 75(4): 791 doi: 10.1007/s43440-023-00489-x
16
Yu. N. Alekhin, V. S. Ponamarev, O. S. Popova. Pathogenetic bases of the combined use of drugs from the groups of hepatoprotectors and phytosorbentsInternational Journal of Veterinary Medicine 2022; (2): 47 doi: 10.52419/issn2072-2419.2022.2.47
17
Xue Li, Xinyi Xu, Sian Tao, Yue Su, Li Wen, Dong Wang, Jibin Liu, Quansheng Feng. Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl4-induced hepatic fibrosisFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1347120